One Study Explored the Effects of Mounjaro Over Several Years

We are currently living in the moment when GLP-1 drugs such as Ozempic and Mounjaro are changing our expectations regarding diabetes, weight loss and fitness. But there’s another big question that goes above and beyond when it comes to these drugs. Can you maintain weight loss in the long term? It’s not an existential issue for the healthcare industry, but it has spurred some pushbacks from skeptics of long-term safety of drugs.

According to a new study, people taking Mounjaro (also known as Tirzepatide) have a cause of relief. GuardianNicola Davis’s recent It has been reported Results of the research to be presented this year European Parliament on Obesity. This study included approximately 700 people and was divided into three groups based on the amount of tilzepatide given.

In the researcher’s findings, Davis wrote that participants in the group lost an average of 9.2%, 20.2%, 20.2%, and 30.8% of their weight. Scientists conducting the study observed that it took an average of 22 months for participants to reach their lowest weight. And the majority of participants lost almost 20% of their starting weight over the course of three years.

Here are some caveats: For starters, Guardianreports state that the study has not been peer-reviewed. However, these results encourage those concerned about the long-term effects of this drug, and whether promising initial outcomes can be maintained over time.